This newsletter is meant to keep you up to date on issues related to vaccines quickly
and easily. We welcome your comments and questions; please email us at
VEC Announcements: November webinar registration now
Registration is now open for the November 13
Current Issues in Vaccines webinar (noon to 1 p.m. ET). Dr. Offit will discuss the
- MenactraÃÂÃÂ®: Should infants receive this vaccine?
- PCV13: Can we give fewer doses?
- Shingles vaccine: How long does it last?
- HPV vaccine: Is a 9-valent vaccine around the corner?
- Influenza vaccine: How well did we do last year?
Continuing education credits will be available. An archive of the event will also be available
later that week.
from the webinar page on our siteÃÂÃÂ»
News and Views: Affordable Care Act ÃÂ¢ÃÂÃÂ Insurance
requirements and the exchange
Charlotte A. Moser, Assistant Director, and Paul A. Offit, Director, Vaccine Education Center
at The ChildrenÃÂ¢ÃÂÃÂs Hospital of Philadelphia
As the country recovers from the recent government shutdown, due in part to Congressional
disagreements related to the Affordable Care Act, it seems a good time to discuss the most recently
implemented aspect of the system ÃÂ¢ÃÂÃÂ the requirement for health insurance.
more about the Affordable Care ActÃÂÃÂ»
In the Journals: Non-medical vaccine exemptions and pertussis in
Paul A. Offit, MD, Director, Vaccine Education Center at The ChildrenÃÂ¢ÃÂÃÂs Hospital of
During the past few years, several studies have shown that immunity to the acellular
pertussis vaccine (DTaP and Tdap) fades more quickly than that found following the whole cell
pertussis vaccine (DTP). The lesser effectiveness of the acellular vaccine has been in part
responsible for the current outbreaks of pertussis throughout the United States. One could then
reasonably ask to what extent, if any, do children whose parents have chosen not to immunize them
contribute to the current outbreaks.
more about how researchers in CA answered this questionÃÂÃÂ»
Ask the Experts: Providing Answers to Your Timely and Challenging Influenza Vaccination
Deborah L. Wexler, MD, Executive Director, Immunization Action Coalition
For vaccinators, new and challenging questions typically surface every influenza season.
And, this certainly is true for the 2013-2014 season, in which a number of new influenza vaccine
products are available for use. Immunization experts from the Centers for Disease Control and
Prevention (CDC) are here to help! Just in time for influenza season, youÃÂ¢ÃÂÃÂll find an up-to-date
collection of more than 70 influenza-related Q&As on the Immunization Action CoalitionÃÂ¢ÃÂÃÂs (IAC)
From the MediaÃÂ ÃÂ¢ÃÂÃÂ Vaccine-related news
As we finalized this issue of the Vaccine Update including a summary of government workers
furloughed during the government shutdown, our leaders in Washington came to some agreement and
everyone returned to work. The result ÃÂ¢ÃÂÃÂ our ÃÂ¢ÃÂÃÂFrom the MediaÃÂ¢ÃÂÃÂ column was no longer helpful to
Therefore, we decided to take this opportunity to draw your attention to our ÃÂ¢ÃÂÃÂVaccine-Related
NewsÃÂ¢ÃÂÃÂ page on the vaccine.chop.edu website.
On the Calendar
Check the calendar for meetings near you!
On the Bookshelf: Anti-vaccine sentiment now
and during the time of smallpox
Charlotte A. Moser, Assistant Director, Vaccine Education Center at The ChildrenÃÂ¢ÃÂÃÂs Hospital of
Garth Williams, author of the
Polio Revisited, previously penned
Angel of Death: The Story of Smallpox. Although first published by Palgrave Macmillan in
2010, the well-researched book is a great read for anyone who works with vaccinations or has an
interest in the social and historical aspects of vaccine-preventable diseases.
Read more about the parallels between arguments against vaccination then and
Resources: Recent Medscape articles and one VIS-related
Recent Medscape articles
Several useful articles related to vaccines and infectious diseases have recently been
posted on Medscape:
You may need to
register for free to
view some or all of these articles.
One VIS-related note
The Centers for Disease Control and Prevention (CDC) posted a
document related to the 2013-2014 influenza vaccine information statements (VISs) specifically
for providers. The seven-page document is intended to be a reference guide when answering questions
about or discussing influenza vaccine and includes sections such as people at highest risk of
complications and their close contacts, immunizing children 6 months through 8 years of age,
precautions and indications and safety.